During the meeting held on May 18th 2017, Julphar Gulf Pharmaceutical Industries’ Board of Directors released the company’s quarterly results and business achievements for the first three months of the year.

The Board discussed the situation in Middle East and North Africa (MENA), impacted by the environment in the Iraqi, Egyptian and Libyan markets, with the company achieving sales amounting"...

The government of Germany will provide the budget for a 200-bed hospital for the Kurdistan Region’s Ministry of Peshmerga, a Kurdish military official said.

The Deputy Chief of Staff in the Peshmerga Ministry, Qaraman Kamal, told NRT on Tuesday (May 23) several companies have put together plans for the Peshmerga forces’ military hospital.

“A number of"...

Cambridge Innovation Capital (CIC), a Cambridge-based investor in technology and healthcare companies, announces that its CEO, Victor Christou, will be presenting at the Global University Venturing: Fusion event in London this evening.

Christou will address the current issues in venture funding, including the substantial gap between seed and scale-up. A recent study of over 1,000 UK science and technology businesses suggests that less than 10% of"...

Boehringer Ingelheim today announced the presentation of new analyses on the use of OFEV® (nintedanib) in treating idiopathic pulmonary fibrosis (IPF) at the 2017 American Thoracic Society (ATS) conference. Abstracts presented at the conference support the established efficacy and safety data for OFEV®, and offer further insights into its effect on lung function in IPF patients.

Pooled data from the two Phase III INPULSIS® trials showed"...

Octapharma announces positive new clinical data in 66 previously treated patients (PTPs) with severe haemophilia A (HA) undergoing PK-guided personalized prophylaxis with Nuwiq® according to the NuPreviq Approach. Data from the NuPreviq study (GENA-21,NCT01863758) were published online in April 2017 as an Early View article in the internationally renowned medical journal, Haemophilia.

The NuPreviq study was initiated in August 2013 with the"...

• Adding tiotropium Respimat® improved lung function and asthma symptom control in children and adolescents,* regardless of their type of allergic asthma, compared to placebo1,2
• The addition of tiotropium Respimat® improved airflow obstruction in adults with symptomatic asthma, independent of body mass index (BMI) compared to placebo3
• In all analyses, people experiencing uncontrolled asthma symptoms saw improvements in their breathing by adding tiotropium Respimat® to an ICS or combination ICS/LABA1,2,3

Boehringer"...

At this year’s World Health Assembly, GE Healthcare and Women in Global Health, a movement that strives for greater gender equality in global health leadership, are joining forces to honor and celebrate women in global health.

Today, women make up 75 percent of the global healthcare workforce in many regions1 and contribute nearly $3 trillion to the industry. But too often their contributions go unpaid and unrecognized – and stories"...

CHECKPOINT Pumps & Systems proudly launch its latest innovation, the Series HDA electric diaphragm chemical injection pump—rising to meet high demand from customers in the Middle East region. The Series HDA comes equipped with a diaphragm dosing head that allows for efficient, environmentally safe injection. The company’s newest addition promises increased reliability fit for any location, especially in remote or unmanned areas, where productive use of resources can offer impressive financial returns.

Qatar Red Crescent (QRCS) has made progress in the comprehensive humanitarian intervention plan it is conducting for the people affected by the ongoing crisis in Mosul, Iraq.

With funding from Qatar Fund for Development (QFFD), QRCS's relief teams has made activities to support the health care, water, and sanitation conditions of the internally displaced people (IDPs).

At"...

• First phase investment of more than €70 million
• The facility is designed to operate 2000L scale single-use bioreactors and fill/finish capabilities
• It is the first and only biopharmaceutical manufacturing site established by a multinational active pharmaceutical company in China

Today, Boehringer Ingelheim inaugurated its commercial production site for biopharmaceuticals in Zhang Jiang Hi-tech Park of Shanghai (China). The site, with the first-phase investment of more than €70"...